EP Patent

EP3801536B1 — Administration of sepiapterin without food for use in a method for increasing sepiapterin plasma exposure

Assigned to PTC Therapeutics MP Inc · Expires 2024-07-17 · 2y expired

What this patent protects

Patent listed against Sephience.

Drugs covered by this patent

Patent Metadata

Patent number
EP3801536B1
Jurisdiction
EP
Classification
—
Expires
2024-07-17
Drug substance claim
No
Drug product claim
No
Assignee
PTC Therapeutics MP Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.